Oncology consulting business Physiomics said it had won two further contracts with existing client Bicycle Therapeutics, with an undisclosed value. The contract award built on two projects announced in 2019. It would involve pharmacokinetic and pharmacodynamic analysis of a number of Bicycle compounds and build on work completed by the company previously. Both projects were expected to be completed in the next six months. At 9:46am: (LON:PYC) Physiomics PLC share price was +0.25p at 2.45p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.